Clinical Microbiology and Infectious Diseases, Hospital Clínico San Carlos, IdISSC and IML Health Institutes, Council of Public Health, Prof Martín Lagos, s/n, 28040 Madrid, Spain.
Scientific & Medical Affairs, Global Health Economics and Outcomes Research, Grifols S.A., Av. Generalitat, 152 (SC3), Sant Cugat del Vallès, 08174 Barcelona, Spain.
Viruses. 2021 May 15;13(5):917. doi: 10.3390/v13050917.
The global COVID-19 spread has forced countries to implement non-pharmacological interventions (NPI) (i.e., mobility restrictions and testing campaigns) to preserve health systems. Spain is one of the most severely impacted countries, both clinically and economically. In an effort to support policy decision-making, we aimed to assess the impacts of different NPI on COVID-19 epidemiology, healthcare costs and Gross Domestic Product (GDP). A modified Susceptible-Exposed-Infectious-Removed epidemiological model was created to simulate the pandemic evolution. Its output was used to populate an economic model to quantify healthcare costs and GDP variation through a regression model which correlates NPI and GDP change from 42 countries. Thirteen scenarios combining different NPI were consecutively simulated in the epidemiological and economic models. Both increased testing and stringency could reduce cases, hospitalizations and deaths. While policies based on increased testing rates lead to higher healthcare costs, increased stringency is correlated with greater GDP declines, with differences of up to 4.4% points. Increased test sensitivity may lead to a reduction of cases, hospitalizations and deaths and to the implementation of pooling techniques that can increase throughput testing capacity. Alternative strategies to control COVID-19 spread entail differing economic outcomes. Decision-makers may utilize this tool to identify the most suitable strategy considering epidemiological and economic outcomes.
全球 COVID-19 的传播迫使各国实施非药物干预措施(即流动性限制和检测活动)以维持卫生系统。西班牙是受影响最严重的国家之一,无论是在临床方面还是在经济方面。为了支持政策决策,我们旨在评估不同非药物干预措施对 COVID-19 流行病学、医疗成本和国内生产总值(GDP)的影响。我们创建了一个改良的易感性-暴露性-感染性-康复流行病学模型来模拟大流行的演变。其输出结果用于填充一个经济模型,通过将 42 个国家的非药物干预措施和 GDP 变化相关联的回归模型来量化医疗成本和 GDP 的变化。在流行病学和经济模型中,我们连续模拟了 13 种不同非药物干预措施的组合。增加检测和严格程度都可以减少病例、住院和死亡人数。虽然基于增加检测率的政策会导致更高的医疗成本,但增加严格程度与 GDP 下降幅度更大相关,最大可达 4.4%。提高检测敏感性可能会减少病例、住院和死亡人数,并实施可增加检测能力的组合技术。控制 COVID-19 传播的替代策略会产生不同的经济结果。决策者可以利用此工具根据流行病学和经济结果来确定最合适的策略。